Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Consolidated Net Profit

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹3,486 Cr₹3,173 Cr₹1,928 Cr₹2,648 Cr₹5,335 Cr

What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?

The latest Consolidated Net Profit ratio of AUROBINDO PHARMA is ₹3,486 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹3,486 Cr
Mar2024₹3,173 Cr
Mar2023₹1,928 Cr
Mar2022₹2,648 Cr
Mar2021₹5,335 Cr

How is Consolidated Net Profit of AUROBINDO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹3,486 Cr
9.86
Mar2024 ₹3,173 Cr
64.62
Mar2023 ₹1,928 Cr
-27.21
Mar2022 ₹2,648 Cr
-50.36
Mar2021 ₹5,335 Cr -

Compare Consolidated Net Profit of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹60,417.7 Cr 1.9% -3% -32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹379,191.0 Cr 1% -0.9% -13% Stock Analytics
DIVIS LABORATORIES ₹159,973.0 Cr -1.6% -1.8% 17.9% Stock Analytics
CIPLA ₹124,507.0 Cr -1.8% 3.7% -6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,175.0 Cr 0.7% 2.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,355.0 Cr -0.6% 4.5% -6.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.9%

-3%

-32.6%

SENSEX

0.5%

0.1%

-2.1%


You may also like the below Video Courses